These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition. Nasli-Esfahani E, Mohammadi-Khanaposhtani M, Rezaei S, Sarrafi Y, Sharafi Z, Samadi N, Faramarzi MA, Bandarian F, Hamedifar H, Larijani B, Hajimiri M, Mahdavi M. Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079 [Abstract] [Full Text] [Related]
6. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors. Asemanipoor N, Mohammadi-Khanaposhtani M, Moradi S, Vahidi M, Asadi M, Faramarzi MA, Mahdavi M, Biglar M, Larijani B, Hamedifar H, Hajimiri MH. Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286 [Abstract] [Full Text] [Related]
7. Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase. Wei M, Chai WM, Wang R, Yang Q, Deng Z, Peng Y. Bioorg Med Chem; 2017 Feb 15; 25(4):1303-1308. PubMed ID: 28110817 [Abstract] [Full Text] [Related]
8. Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents. Sayahi MH, Zareei S, Halimi M, Alikhani M, Moazzam A, Mohammadi-Khanaposhtani M, Mojtabavi S, Faramarzi MA, Rastegar H, Taslimi P, Ibrahim EH, Ghramh HA, Larijani B, Mahdavi M. Sci Rep; 2024 Jul 09; 14(1):15791. PubMed ID: 38982268 [Abstract] [Full Text] [Related]
13. Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies. Asgari MS, Mohammadi-Khanaposhtani M, Sharafi Z, Faramarzi MA, Rastegar H, Nasli Esfahani E, Bandarian F, Ranjbar Rashidi P, Rahimi R, Biglar M, Mahdavi M, Larijani B. Mol Divers; 2021 May 09; 25(2):877-888. PubMed ID: 32189236 [Abstract] [Full Text] [Related]
14. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3). Madasu C, Karri S, Sangaraju R, Sistla R, Uppuluri MV. Eur J Med Chem; 2020 Feb 15; 188():111974. PubMed ID: 31883489 [Abstract] [Full Text] [Related]
15. New carbazole linked 1,2,3-triazoles as highly potent non-sugar α-glucosidase inhibitors. Iqbal S, Khan MA, Javaid K, Sadiq R, Fazal-Ur-Rehman S, Choudhary MI, Basha FZ. Bioorg Chem; 2017 Oct 15; 74():72-81. PubMed ID: 28756277 [Abstract] [Full Text] [Related]
16. Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic. Sherafati M, Mirzazadeh R, Barzegari E, Mohammadi-Khanaposhtani M, Azizian H, Sadegh Asgari M, Hosseini S, Zabihi E, Mojtabavi S, Ali Faramarzi M, Mahdavi M, Larijani B, Rastegar H, Hamedifar H, Hamed Hajimiri M. Bioorg Chem; 2021 Apr 15; 109():104703. PubMed ID: 33609917 [Abstract] [Full Text] [Related]
17. Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity. Chinthala Y, Thakur S, Tirunagari S, Chinde S, Domatti AK, Arigari NK, K V N S S, Alam S, Jonnala KK, Khan F, Tiwari A, Grover P. Eur J Med Chem; 2015 Mar 26; 93():564-73. PubMed ID: 25743216 [Abstract] [Full Text] [Related]
18. New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetes. Ansariashlaghi S, Fakhrioliaei A, Mohammadi-Khanaposhtani M, Noori M, Asadi M, Mojtabavi S, Faramarzi MA, Esfahani EN, Rastegar H, Larijani B, Azizian H, Mahdavi M. Arch Pharm (Weinheim); 2024 Jul 26; 357(7):e2300517. PubMed ID: 38593290 [Abstract] [Full Text] [Related]
19. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Nasli Esfahani E, Mahdavi M, Larijani B. Bioorg Chem; 2018 Oct 26; 80():288-295. PubMed ID: 29980114 [Abstract] [Full Text] [Related]
20. Synthesis, in vitro evaluation, and molecular docking studies of novel hydrazineylideneindolinone linked to phenoxymethyl-1,2,3-triazole derivatives as potential α-glucosidase inhibitors. Shareghi-Boroujeni D, Iraji A, Mojtabavi S, Faramarzi MA, Akbarzadeh T, Saeedi M. Bioorg Chem; 2021 Jun 26; 111():104869. PubMed ID: 33839583 [Abstract] [Full Text] [Related] Page: [Next] [New Search]